XML 31 R30.htm IDEA: XBRL DOCUMENT
v3.2.0.727

License Agreement/Revenue Recognition - Additional Information (Detail) - USD ($) | 1 Months Ended | 9 Months Ended
--- | --- | ---
Apr. 30, 2014 | Mar. 31, 2015
Ampio [Member] | KOREA |  |
Revenue Recognition [Line Items] |  |
Upfront payment received |  | $ 500,000
Upfront payment received, net proceed |  | 418,000
Milestone payments that may be earned and recognized |  | $ 3,200,000
Deferred revenue recognition period |  | 10 years
Royalty percentage of net sales |  | 25.00%
Vyrix Pharmaceuticals [Member] |  |
Revenue Recognition [Line Items] |  |
Upfront payment received | $ 250,000 |
Milestone payments that may be earned and recognized | $ 3,025,000 |
Deferred revenue recognition period | 7 years |
Agreement expiration period | 15 years |

X
- Definition Agreement expiration period. + References No definition available. + Details
Name: | rswn_AgreementExpirationPeriod
Namespace Prefix: | rswn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Deferred Revenue Recognition Period + References No definition available. + Details
Name: | rswn_DeferredRevenueRecognitionPeriod
Namespace Prefix: | rswn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage Of Royalty Rate Of Net Sales + References No definition available. + Details
Name: | rswn_PercentageOfRoyaltyRateOfNetSales
Namespace Prefix: | rswn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Potential Milestone Payments Receivable + References No definition available. + Details
Name: | rswn_PotentialMilestonePaymentsReceivable
Namespace Prefix: | rswn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Revenue Recognition [Line Items] + References No definition available. + Details
Name: | rswn_RevenueRecognitionLineItems
Namespace Prefix: | rswn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section A + Details
Name: | us-gaap_DeferredRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Cash received from licensees for license fees during the current period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=rswn_AmpioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_KR
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=rswn_VyrixPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |